- C
- N
- O
Calculated reference model · not an experimental or batch-certified structure. All 18 atoms shown.
Model data & sources
- Heavy atoms only; hydrogens are omitted from the reference display.
- Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
- Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
- Formula
- C14H18N2O2
- Method
- RDKit ETKDGv3 / MMFF94s calculated reference conformer
- Batch
- KC-NEF-02
Nefiracetam
NootropicsPublished formats
- Dry-Fill Capsule 120ct/100mg/12g
- Powder 20g
What is the difference between these?
- Dry-Fill Capsule
- Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
- Powder
- Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.
Pricing
Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.
Technical Specifications
Batch COA Database ↗Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.
Research Overview
Nefiracetam Research Standard
Nefiracetam is an N-phenyl-substituted pyrrolidone derivative belonging to the racetam family of compounds. Its unique chemical structure—characterized by high lipophilicity—facilitates distinct pharmacological interactions within neural tissues. In laboratory research, it is primarily utilized to investigate mechanisms of neuroplasticity, cholinergic neurotransmission, and calcium channel modulation. Unlike foundational racetams, Nefiracetam acts as a potent tool for studying the fine-tuning of synaptic signaling and the mitigation of cellular stress responses in neuronal models.
Physical & Handling Properties
| Property | Specification |
|---|---|
| Physical Appearance | White to off-white / light yellow crystalline powder |
Mechanism of Action & Research Context
Nefiracetam is researched for its multi-target interactions within the central nervous system, particularly its influence on excitatory and inhibitory signaling pathways.
-
Calcium Channel Modulation: Research highlights its ability to facilitate the activity of voltage-dependent calcium channels (specifically N-type and L-type), which is central to its role in enhancing neurotransmitter release.
-
Cholinergic Enhancement: The compound is widely used to study the sustained enhancement of acetylcholine (ACh) release in the hippocampus, a pathway critical for studying memory formation and synaptic plasticity.
-
GABAergic & Glutamatergic Signaling: Investigations utilize Nefiracetam to observe its modulatory effects on GABA receptors and its potential to counteract excitotoxicity via glutamate pathway regulation.
-
Neuroplasticity: Through these mechanisms, the compound serves as a probe for observing structural changes in neuronal connections and the molecular basis of long-term potentiation (LTP).
Research Applications
Nefiracetam is a specialized reference compound for studying cognitive pharmacology and neuroprotection.
Primary fields of in vitro laboratory investigation include:
-
Synaptic Plasticity Studies: Exploring cellular models of learning and information processing by measuring changes in synaptic efficiency.
-
Calcium Channel Dynamics: Quantifying ion flux through nerve cell membranes in the presence of N-phenyl-substituted pyrrolidones.
-
Neuroprotective Research: Observing cellular responses to oxidative or metabolic stress to evaluate the potential of racetam-class molecules to mitigate nerve cell damage.
-
Receptor Signaling: Examining the interaction between the pyrrolidone nucleus and various neurotransmitter sites (GABA, ACh).
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
References
-
Nishizaki T, et al. (1999) “Nefiracetam facilitates neurotransmission by stimulating the activity of N-type Ca2+ channels.” Journal of Biological Chemistry. 274(2): 895–902.
-
Moriguchi S, et al. (2003) “Nefiracetam enhances long-term potentiation and synaptic transmission in the hippocampus.” Neuropharmacology. 45(4): 509–518.
-
Karasawa J, et al. (1997) “Nefiracetam: a novel cognitive enhancer.” CNS Drug Reviews. 3(2): 179–191.
Related Research Compounds
Research Use Disclaimer
Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.
Certificates of Analysis
- Batch KC-NEF-02 2 reports
Currently shipping from batch KC-NEF-02.

Compounds That Survive Scrutiny
Research use only. Not for human or veterinary use.